Building on our strong domestic base, we are further expanding the international business
Our products are developed in full compliance with EU, US or other international guidelines as required. We have teams with specialist expertise for New Zealand, Australia, Asia, the Americas, Europe and South Africa regulatory requirements. Our patent attorney provides advice and support to ensure any potential patent issues are highlighted and addressed during the development of our products.
Advantageous legislation in both New Zealand and Fiji allows us to develop any pharmaceutical product while still under patent. For many products early patent expiry in New Zealand allows for the manufacture of launch stocks, particularly for export markets.